Siegfried, a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, has signed binding agreements with an affiliate of SK Capital Partners to acquire the drug substance business of the Noramco Group and Extractas Bioscience. The acquired businesses include three high…
MS Pharma Group, a leading regional pharmaceutical company in the MENA region, has signed a strategic partnership agreement with Hetero Group, a global pharmaceutical company, to localize five established biosimilars across key therapeutic areas, including oncology, immunology and hematology. The exclusive agreement…
Thermo Fisher Scientific Inc., the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The effort will leverage the NVIDIA Artificial Intelligence (AI) platform and Thermo Fisher Scientific solutions to progressively increase …
BD, a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate® 5.5 a…
Syngene International, a global contract research, development, and manufacturing organization, announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning di…
Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), and Hygtia Therapeutics Co., Ltd., (Hygtia Therapeutics), announced a co-development collaboration agreement for Insilico's ISM8969 program. Through the partnership, the two parties aim to accelerate the globa…
Genezen, a leading gene therapy contract development and manufacturing organization (CDMO), and Atsena Therapeutics ("Atsena"), a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, announced a strategic manufacturing partnership to advance …
GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on the sidelines of the 44th Annual J.P. Morgan Healthcare Conference 2026 in San Francisco, USA, to expand their collabora…
Zydus Lifesciences Limited is an innovation-led life-sciences company with an international presence, announced the successful closure of the Asset Purchase Agreement, Share Purchase Agreement, and the exclusive Licensing Agreement with Agenus Inc. This comprehensive closure follows the receipt of all the necessary re…
Boston Scientific Corporation and Penumbra, Inc., announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion. "Penumbra is a w…
Page 21 of 40